亚太膝关节软骨修复市场 – 行业趋势及 2030 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

亚太膝关节软骨修复市场 – 行业趋势及 2030 年预测

  • Medical Devices
  • Published Report
  • Feb 2023
  • Asia-Pacific
  • 350 页面
  • 桌子數: 251
  • 图号: 43

Asia Pacific Knee Cartilage Repair Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2024 –2030
Diagram Market Size (Base Year)
USD MILLION
Diagram Market Size (Forecast Year)
USD MILLION
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

>亚太膝关节软骨修复市场,按产品(基于细胞和非基于细胞)、方式(骨软骨移植、微骨折、磨损关节成形术、钻孔、软骨细胞植入等)、软骨类型(透明软骨和纤维软骨)、应用(骨关节炎、类风湿性关节炎、骨坏死、骨折、骨肿瘤等)、最终用户(医院、门诊手术中心、专科诊所、研究和学术机构等)、分销渠道(直销、第三方分销商、在线销售等)、行业趋势和预测到 2030 年。

亚太膝关节软骨修复市场

亚太膝关节软骨修复市场分析与洞察

预计该产品的推出将推动行业发展,增加膝关节疾病膝关节软骨修复产品的销售和分销。该产品的推出将产生新的合作伙伴关系和业务合作。该产品的推出将使客户能够购买他们可用的新产品。该产品的推出可能会描绘出市场增长的积极趋势。

亚太膝关节软骨修复市场

亚太膝关节软骨修复市场

此外,膝关节疾病发病率上升、老年人口增加、亚太地区膝关节治疗意识增强以及膝关节软骨修复器械技术发展预计将推动市场增长。主要市场参与者采取的战略举措也将在预测期内推动市场增长。

然而,膝关节手术的高成本以及使用膝关节矫形器时面临的问题预计会抑制市场的增长。

Data Bridge Market Research分析,亚太膝关节软骨修复市场在2023年至2030年的预测期内将以11.1%的复合年增长率增长。

报告指标

细节

预测期

2023 至 2030 年

基准年

2022

历史岁月

2021 (可定制为 2020-2016)

定量单位

收入(百万美元)、销量(单位)、定价(美元)

涵盖的领域

按产品(基于细胞和非基于细胞)、方式(骨软骨移植、微骨折、磨损关节成形术、钻孔、软骨细胞植入等)、软骨类型(透明软骨和纤维软骨)、应用(骨关节炎、类风湿性关节炎、骨坏死、骨折、骨肿瘤等)、最终用户(医院、门诊手术中心、专科诊所、研究和学术机构等)、分销渠道(直销、第三方分销商、在线销售等)。

覆盖国家

日本、中国、韩国、印度、澳大利亚、新加坡、泰国、马来西亚、印度尼西亚、菲律宾、越南和亚太地区其他地区。

涵盖的市场参与者

Stryker, Zimmer Biomet, B. Braun Melsungen AG, Smith & Nephew, BioTissue, CONMED, DePuy Synthes Companies (A part of Johnson & Johnson Medical Devices Companies), Arthrex, Inc., Medacta International, Regrow Biosciences Pvt. Ltd., Regentis Biomaterials Ltd., Anika Therapeutics, Inc., Auxein Medical, BioGend Therapeutics Co., Ltd., CartiHeal, Inc. (A subsidiary of Bioventus Inc.), MEDIPOST, Sartorius CellGenix GmbH, Sanofi and Waldemar Link GmbH & Co. KG, Geistlich Pharma AG, among others

Market Definition:

The knee is the largest joint in the body. The upper and lower bones of the knee are separated by two discs (menisci). The upper leg bone (femur) and the lower leg bones (tibia and fibula) are connected by ligaments and tendons. Cartilage is the most common type of connective tissue. It is found in various forms throughout our joints, spine, bones, ears, lungs, and nose. Cartilage is a flexible connective tissue that coats the surfaces of the bones in our joints and protects them against impact to maintain joint mobility fluid.

Knee cartilage repair is a procedure that involves repairing damaged cartilage while also smoothing the tissue's remaining surface. Cartilage repair surgery, which attempts to restore cartilage tissue and function to avoid long-term osteoarthritis, is an appropriate treatment choice for focal full-thickness cartilage abnormalities in the knee. Osteotomy, knee replacement, and microfracture are some of the most common knee cartilage repair techniques. The surgical techniques or less prevalent surgical procedures, such as allograft osteochondral transplantation, autologous chondrocyte implantation, and artificial scaffolds, are sometimes utilized to repair cartilage injury.

Asia-Pacific Knee Cartilage Repair Market Dynamics

Drivers

  • INCREASE IN THE PREVALENCE OF KNEE DISORDERS

The most common joint disorder among the elderly is knee osteoarthritis (OA), where the destruction and loss of articular cartilage is a central feature in most forms of arthritis, including the most common form that is osteoarthritis. With osteoarthritis, the cartilage within a joint begins to break down, and the underlying bone changes. It not only causes patients pain and physical impairment but also imposes a significant disease burden on the population as a whole. Years Lived with Disability (YLD) is the standard metric to quantify disease burden in most chronic diseases, such as osteoarthritis. One year of disability is equivalent to one year of "healthy" life lost. The sum of YLDs across the population, the disease burden, represents the difference between current health status and an ideal health situation in which the entire population lives to an advanced age free of disease and disability. The rise in the incidence of chronic knee disorders is expected to boost the sales and supply of medication and implants for the treatment of knees in Asia-Pacific. It is expected to meet the patient's requirements. The knowledge about the prevalence and incidence of orthopedic knee diseases would help find novel solutions and aid in more collaborations and partnerships with market players based in countries in the Asia-Pacific region. Hence, the rise in knee disorders is expected to boost market growth.

  • RISE IN THE NUMBER OF KNEE SURGERIES

Hip and knee replacements and surgeries are some of the most frequently performed and effective surgeries in Asia-Pacific. Osteoarthritis is the main indication for hip and knee replacement and surgery as osteoarthritis is also the reason for cartilage damage and destruction of the articular cartilage, so the surgeries due to osteoarthritis also involve cartilage repair. Knee surgeries are becoming quite common in Asia-Pacific due to the growing prevalence of sports-related knee injuries and expanding indications for total knee replacement due to patient and surgeon preferences.

The rise in knee surgeries in Asia-Pacific countries would ensure timely awareness and treatment of patients with chronic knee morbidities. Technological development would be of crucial importance in the development of advanced knee implants. Further optimization and novel technological developments would open the use of 3D implants. The rise in the number of knee surgeries is expected to drive the Asia-Pacific knee cartilage repair market growth.

亚太膝关节软骨修复市场

Opportunities

  • RISE IN AWARENESS ABOUT KNEE TREATMENT

Understanding knee disorders and the scope of the treatment is vital to help and guiding people suffering from osteoarthritis and meniscal injuries. It helps in achieving early detection and management. Awareness about the symptoms and treatment of chronic knee diseases by public and private institutes would result in timely treatment and provide access to inexpensive universal health aid along with increased availability of rehabilitative treatment. The Asia-Pacific Knee Society (APKS) was created to bring the key opinion leaders in the field of Asia-Pacific's degenerative knee and knee arthroplasty together and gather valuable information about growing trends and awareness.

The awareness about the early treatment and use of knee implants would result in collaborations of market players with health institutions to supply and distribute the devices. This will result in a rise in product and business line expansion. Hence, a rise in awareness among people about timely treatment is expected to act as an opportunity for market growth.

  • GROWING GERIATRIC POPULATION

Knee disorders, namely knee osteoarthritis, and ligament tears, are common in the elderly population in Asia-Pacific. Bone problems are likely to affect persons 60 years and older, especially those residing in long-term care institutions. As the elderly population ages, the prevalence of knee diseases may rise, opening the door for the development of drugs and implants in diagnostic and preventive methods vital for improving knee disorders in older persons. Along with other risk factors, the vulnerability to knee diseases also increases with age. Osteoarthritis of the knee can be brought on by injury, infection, or being overweight, or it might be inherited in certain people. Women are more likely to experience the same.

A type of connective tissue called cartilage can be found throughout the body. Despite being a strong and flexible material, it is relatively simple to harm. Additionally, the cartilage gradually deteriorates with age, and osteoarthritis sufferers frequently experience stiffness, especially after prolonged periods of sitting or lying down. The joints' capacity to withstand demands decreases as the body's natural shock absorbers deteriorate. With advancing age, bone density and muscle tone gradually deteriorate, making physically demanding occupations even more challenging. Therefore, the expanding elderly population experiences more bone and joint problems that require early treatment and are therefore anticipated to propel market expansion.

As the geriatric population increases and suffering from chronic knee increases, it would result in increased treatment demand. Therefore, the rise in the geriatric population is expected to boost the growth of the market.

Restraints/Challenges

  • HIGH COST OF THE ORTHOPEDIC KNEE IMPLANTS AND SURGERIES

Knee arthroplasty is a popular procedure but exhibits a high cost. The cost of knee implants is due to technological development and the rising preference for less invasive orthopedic knee implants.

The cost of Autologous Chondrocyte Implantation (ACI) is expensive. Osteochondral allograft transplantation is a specialized procedure. Its cost is thus high depending upon the cost of the allografts. It ranges from around $10,000.  Hence, it is expected to hamper the market growth.

Post-COVID-19 Impact on Asia-Pacific Knee Cartilage Repair Market

COVID-19 has negatively affected the market. Lockdowns and isolation during the pandemic complicate disease management and medication adherence. The lack of access to healthcare facilities for routine treatment and medication administration has impacted the market.

Recent Development

  • In March 2022, CritiCare Asia launched Cuvis 3rd Generation Robotic Arm Technology for joint replacement surgeries to enable surgeons to perform complex joint replacement surgeries precisely by overcoming the challenges they face during traditional open surgeries. This way, artificial intelligence aid the surgeries with minimally invasive.

Asia-Pacific Knee Cartilage Repair Market Scope

The Asia-Pacific knee cartilage repair market is categorized into six segments based on product, modality, cartilage type, application, end user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

  • Cell-Based
  • Non-Cell-Based

Based on product, the Asia-Pacific knee cartilage repair market is segmented into cell-based and non-cell-based.

Modality

  • Osteochondral Transplantation
  • Microfracture
  • Abrasion Arthroplasty
  • Drilling
  • Chondrocyte Implantation
  • Others

Based on modality, the Asia-Pacific knee cartilage repair market is segmented into chondrocyte implantation, microfracture, drilling, abrasion arthroplasty, osteochondral transplantation, and others.

Cartilage Type

  • Hyaline Cartilage
  • Fibrocartilage

Based on cartilage type, the Asia-Pacific knee cartilage repair market is segmented into hyaline cartilage and fibrocartilage.

Application

  • Osteoarthritis
  • Rheumatoid Arthritis
  • Bone Tumors
  • Fractures
  • Steonecrosis

Based on application, the Asia-Pacific knee cartilage repair market is segmented into osteoarthritis, rheumatoid arthritis, bone tumors, fractures, and steonecrosis.

End User

  • Hospital
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Research And Academic Institutes
  • Others

Based on end user, the Asia-Pacific knee cartilage repair market is segmented into hospital, ambulatory surgical centers, specialty clinics, research and academic institutes, and others.

Distribution Channel

  • Direct Sales
  • Third Party Distributor
  • Online Sales
  • Others

根据分销渠道,亚太膝关节软骨修复市场分为直销、第三方分销商、在线销售和其他。

亚太膝关节软骨修复市场

亚太地区膝关节软骨修复区域分析/见解

对亚太膝关节软骨修复市场进行了分析,并按国家、产品、方式、软骨类型、应用、最终用户和分销渠道提供了市场规模洞察和趋势,如上所述。

由于膝关节疾病病例增加和老年人口不断增长,亚太地区膝关节软骨修复市场预计将增长。与骨质疏松症和事故病例相关的骨折风险增加也推动了市场增长。此外,市场参与者在该地区推出先进产品的举措不断增加,将在预测期内进一步促进市场增长。

由于技术先进、膝关节骨关节炎发病率高以及医疗保健体系完善,中国有望主导亚太膝关节软骨修复市场。

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场法规变化。新销售、替代销售、国家人口统计、疾病流行病学和进出口关税等数据点是用于预测各个国家市场情景的一些主要指标。此外,在对国家数据进行预测分析时,还考虑了其​​他品牌的存在和可用性以及由于来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、销售渠道的影响。

竞争格局和亚太膝关节软骨修复市场份额分析

亚太膝关节软骨修复市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、国家/地区分布、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对亚太膝关节软骨修复市场的关注有关。

亚太膝关节软骨修复市场的一些主要参与者包括 Stryker、Zimmer Biomet、B. Braun Melsungen AG、Smith & Nephew、BioTissue、CONMED、DePuy Synthes Companies(强生医疗器械公司的一部分)、Arthrex, Inc.、Medacta International、Regrow Biosciences Pvt. Ltd.、Regentis Biomaterials Ltd.、Anika Therapeutics, Inc.、Auxein Medical、BioGend Therapeutics Co., Ltd.、CartiHeal, Inc.(Bioventus Inc. 的子公司)、MEDIPOST、Sartorius CellGenix GmbH、Sanofi and Waldemar Link GmbH & Co. KG、Geistlich Pharma AG 等。


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 TREATMENT SEGMENT LIFELINE CURVE

2.8 DBMR MARKET POSITION GRID

2.9 MARKET APPLICATION COVERAGE GRID

2.1 SECONDARY SOURCES

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTER'S FIVE FORCES MODEL

4.3 PATENT ANALYSIS

5 INDUSTRIAL INSIGHTS

6 EPIDEMIOLOGY

7 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, REGULATION

8 MARKET OVERVIEW

8.1 DRIVERS

8.1.1 INCREASE IN THE PREVALENCE OF KNEE DISORDERS

8.1.2 RISE IN THE NUMBER OF KNEE SURGERIES

8.1.3 GROWTH IN TECHNOLOGICAL ADVANCEMENTS

8.1.4 INCREASE IN DEMAND FOR MINIMALLY INVASIVE PROCEDURES

8.2 RESTRAINTS

8.2.1 HIGH COST OF THE ORTHOPEDIC KNEE IMPLANTS AND SURGERIES

8.2.2 RISE IN CONCERN REGARDING METAL SENSITIVITY IN PATIENTS WITH KNEE IMPLANTS

8.3 OPPORTUNITIES

8.3.1 RISE IN AWARENESS ABOUT KNEE TREATMENT

8.3.2 GROWING GERIATRIC POPULATION

8.3.3 HIGH PREVALENCE OF KNEE INJURIES

8.4 CHALLENGES

8.4.1 LACK OF SKILLED PROFESSIONALS

8.4.2 STRINGENT REGULATIONS

9 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY PRODUCT

9.1 OVERVIEW

9.2 CELL BASED

9.2.1 CHONDROCYTE TRANSPLANTATION

9.2.2 STEM CELL

9.2.3 GROWTH FACTORS

9.3 NON-CELL BASED

9.3.1 TISSUE SCAFFOLDS

9.3.2 CELL-FREE COMPOSITES

10 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY MODALITY

10.1 OVERVIEW

10.2 CHONDROCYTE IMPLANTATION

10.3 MICROFRACTURE

10.4 DRILLING

10.5 ABRASION ARTHROPLASTY

10.6 OSTEOCHONDRAL TRANSPLANTATION

10.7 OTHERS

11 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE

11.1 OVERVIEW

11.2 HYALINE CARTILAGE

11.3 FIBROCARTILAGE

12 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY APPLICATION

12.1 OVERVIEW

12.2 OSTEOARTHRITIS

12.3 RHEUMATOID ARTHRITIS

12.4 FRACTURES

12.5 BONE TUMORS

12.6 OSTEONECROSIS

12.7 OTHERS

13 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY END USER

13.1 OVERVIEW

13.2 HOSPITALS

13.2.1 BY TYPE

13.2.1.1 PRIVATE

13.2.1.2 PUBLIC

13.2.2 BY SIZE

13.2.2.1 LARGE

13.2.2.2 MEDIUM

13.2.2.3 SMALL

13.3 AMBULATORY SURGICAL CENTERS

13.4 SPECIALTY CLINICS

13.5 RESEARCH AND ACADEMIC INSTITUTES

13.6 OTHERS

14 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL

14.1 OVERVIEW

14.2 DIRECT SALES

14.3 THIRD PARTY DISTRIBUTORS

14.4 ONLINE SALES

14.5 OTHERS

15 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY COUNTRY

15.1 CHINA

15.2 JAPAN

15.3 INDIA

15.4 SOUTH KOREA

15.5 AUSTRALIA

15.6 THAILAND

15.7 MALAYSIA

15.8 SINGAPORE

15.9 INDONESIA

15.1 VIETNAM

15.11 PHILIPPINES

15.12 REST OF ASIA-PACIFIC

16 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, COMPANY LANDSCAPE

16.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

17 SWOT ANALYSIS

18 COMPANY PROFILES

18.1 SANOFI

18.1.1 COMPANY SNAPSHOT

18.1.2 REVENUE ANALYSIS

18.1.3 RODUCT PORTFOLIO

18.1.4 RECENT DEVELOPMENT

18.2 ZIMMER BIOMET

18.2.1 COMPANY SNAPSHOT

18.2.2 REVENUE ANALYSIS

18.2.3 PRODUCT PORTFOLIO

18.2.4 RECENT DEVELOPMENTS

18.3 SMITH & NEPHEW

18.3.1 COMPANY SNAPSHOT

18.3.2 REVENUE ANALYSIS

18.3.3 PRODUCT PORTFOLIO

18.3.4 RECENT DEVELOPMENTS

18.4 STRYKER

18.4.1 COMPANY SNAPSHOT

18.4.2 REVENUE ANALYSIS

18.4.3 PRODUCT PORTFOLIO

18.4.4 RECENT DEVELOPMENTS

18.5 MEDIPOST

18.5.1 COMPANY SNAPSHOT

18.5.2 REVENUE ANALYSIS

18.5.3 PRODUCT PORTFOLIO

18.5.4 RECENT DEVELOPMENT

18.6 ARTHREX, INC.

18.6.1 COMPANY SNAPSHOT

18.6.2 PRODUCT PORTFOLIO

18.6.3 RECENT DEVELOPMENT

18.7 ANIKA THERAPEUTICS, INC.

18.7.1 COMPANY SNAPSHOT

18.7.2 REVENUE ANALYSIS

18.7.3 PRODUCT PORTFOLIO

18.7.4 RECENT DEVELOPMENT

18.8 AUXEIN MEDICAL

18.8.1 COMPANY SNAPSHOT

18.8.2 PRODUCT PORTFOLIO

18.8.3 RECENT DEVELOPMENTS

18.9 B. BRAUN MELSUNGEN AG

18.9.1 COMPANY SNAPSHOT

18.9.2 PRODUCT PORTFOLIO

18.9.3 RECENT DEVELOPMENTS

18.1 BIOGEND THERAPEUTICS CO., LTD.

18.10.1 COMPANY SNAPSHOT

18.10.2 PRODUCT PORTFOLIO

18.10.3 RECENT DEVELOPMENTS

18.11 BIOTISSUE

18.11.1 COMPANY SNAPSHOT

18.11.2 PRODUCT PORTFOLIO

18.11.3 RECENT DEVELOPMENT

18.12 CONMED

18.12.1 COMPANY SNAPSHOT

18.12.2 REVENUE ANALYSIS

18.12.3 PRODUCT PORTFOLIO

18.12.4 RECENT DEVELOPMENT

18.13 CARTIHEAL, INC. (A SUBSIDIARY OF BIOVENTUS INC.)

18.13.1 COMPANY SNAPSHOT

18.13.2 REVENUE ANALYSIS

18.13.3 PRODUCT PORTFOLIO

18.13.4 RECENT DEVELOPMENT

18.14 DEPUY SYNTHES COMPANIES (A PART OF JHONSON & JHONSON MEDICAL DEVICES COMPANIES)

18.14.1 COMPANY SNAPSHOT

18.14.2 REVENUE ANALYSIS

18.14.3 PRODUCT PORTFOLIO

18.14.4 RECENT DEVELOPMENT

18.15 GEISTLICH PHARMA AG

18.15.1 COMPANY SNAPSHOT

18.15.2 PRODUCT PORTFOLIO

18.15.3 RECENT DEVELOPMENTS

18.16 MEDACTA INTERNATIONAL

18.16.1 COMPANY SNAPSHOT

18.16.2 PRODUCT PORTFOLIO

18.16.3 RECENT DEVELOPMENT

18.17 REGENTIS BIOMATERIALS LTD.

18.17.1 COMPANY SNAPSHOT

18.17.2 PRODUCT PORTFOLIO

18.17.3 RECENT DEVELOPMENTS

18.18 REGROW BIOSCIENCES PVT LTD.

18.18.1 COMPANY SNAPSHOT

18.18.2 PRODUCT PORTFOLIO

18.18.3 RECENT DEVELOPMENTS

18.19 SARTORIUS CELLGENIX GMBH

18.19.1 COMPANY SNAPSHOT

18.19.2 PRODUCT PORTFOLIO

18.19.3 RECENT DEVELOPMENT

18.2 WALDEMAR LINK GMBH & CO. KG

18.20.1 COMPANY SNAPSHOT

18.20.2 PRODUCT PORTFOLIO

18.20.3 RECENT DEVELOPMENTS

19 QUESTIONNAIRE

20 RELATED REPORTS

表格列表

TABLE 1 NUMBER OF INDIVIDUALS AFFECTED BY METAL

TABLE 2 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 3 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (UNITS)

TABLE 4 ASIA-PACIFIC CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 5 ASIA-PACIFIC CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)

TABLE 6 ASIA-PACIFIC NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 7 ASIA-PACIFIC NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)

TABLE 8 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 9 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (UNITS)

TABLE 10 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (USD MILLION)

TABLE 11 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (UNITS)

TABLE 12 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 13 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (UNITS)

TABLE 14 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 15 ASIA-PACIFIC HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 16 ASIA-PACIFIC HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY SIZE, 2021-2030 (USD MILLION)

TABLE 17 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 18 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 19 CHINA KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 20 CHINA KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (UNITS)

TABLE 21 CHINA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 22 CHINA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)

TABLE 23 CHINA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)

TABLE 24 CHINA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 25 CHINA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)

TABLE 26 CHINA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)

TABLE 27 CHINA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 28 CHINA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (UNITS)

TABLE 29 CHINA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (ASP)

TABLE 30 CHINA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (USD MILLION)

TABLE 31 CHINA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (UNITS)

TABLE 32 CHINA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030, (ASP)

TABLE 33 CHINA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 34 CHINA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (UNITS)

TABLE 35 CHINA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (ASP)

TABLE 36 CHINA KNEE CARTILAGE REPAIR MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 37 CHINA HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 38 CHINA HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY SIZE, 2021-2030 (USD MILLION)

TABLE 39 CHINA KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 40 JAPAN KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 41 JAPAN KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (UNITS)

TABLE 42 JAPAN CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 43 JAPAN CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)

TABLE 44 JAPAN CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)

TABLE 45 JAPAN NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 46 JAPAN NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)

TABLE 47 JAPAN NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)

TABLE 48 JAPAN KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 49 JAPAN KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (UNITS)

TABLE 50 JAPAN KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (ASP)

TABLE 51 JAPAN KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (USD MILLION)

TABLE 52 JAPAN KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (UNITS)

TABLE 53 JAPAN KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030, (ASP)

TABLE 54 JAPAN KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 55 JAPAN KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (UNITS)

TABLE 56 JAPAN KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (ASP)

TABLE 57 JAPAN KNEE CARTILAGE REPAIR MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 58 JAPAN HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 59 JAPAN HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY SIZE, 2021-2030 (USD MILLION)

TABLE 60 JAPAN KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 61 INDIA KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 62 INDIA KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (UNITS)

TABLE 63 INDIA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 64 INDIA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)

TABLE 65 INDIA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)

TABLE 66 INDIA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 67 INDIA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)

TABLE 68 INDIA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)

TABLE 69 INDIA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 70 INDIA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (UNITS)

TABLE 71 INDIA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (ASP)

TABLE 72 INDIA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (USD MILLION)

TABLE 73 INDIA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (UNITS)

TABLE 74 INDIA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030, (ASP)

TABLE 75 INDIA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 76 INDIA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (UNITS)

TABLE 77 INDIA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (ASP)

TABLE 78 INDIA KNEE CARTILAGE REPAIR MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 79 INDIA HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 80 INDIA HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY SIZE, 2021-2030 (USD MILLION)

TABLE 81 INDIA KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 82 SOUTH KOREA KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 83 SOUTH KOREA KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (UNITS)

TABLE 84 SOUTH KOREA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 85 SOUTH KOREA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)

TABLE 86 SOUTH KOREA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)

TABLE 87 SOUTH KOREA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 88 SOUTH KOREA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)

TABLE 89 SOUTH KOREA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)

TABLE 90 SOUTH KOREA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 91 SOUTH KOREA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (UNITS)

TABLE 92 SOUTH KOREA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (ASP)

TABLE 93 SOUTH KOREA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (USD MILLION)

TABLE 94 SOUTH KOREA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (UNITS)

TABLE 95 SOUTH KOREA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030, (ASP)

TABLE 96 SOUTH KOREA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 97 SOUTH KOREA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (UNITS)

TABLE 98 SOUTH KOREA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (ASP)

TABLE 99 SOUTH KOREA KNEE CARTILAGE REPAIR MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 100 SOUTH KOREA HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 101 SOUTH KOREA HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY SIZE, 2021-2030 (USD MILLION)

TABLE 102 SOUTH KOREA KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 103 AUSTRALIA KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 104 AUSTRALIA KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (UNITS)

TABLE 105 AUSTRALIA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 106 AUSTRALIA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)

TABLE 107 AUSTRALIA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)

TABLE 108 AUSTRALIA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 109 AUSTRALIA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)

TABLE 110 AUSTRALIA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)

TABLE 111 AUSTRALIA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 112 AUSTRALIA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (UNITS)

TABLE 113 AUSTRALIA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (ASP)

TABLE 114 AUSTRALIA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (USD MILLION)

TABLE 115 AUSTRALIA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (UNITS)

TABLE 116 AUSTRALIA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030, (ASP)

TABLE 117 AUSTRALIA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 118 AUSTRALIA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (UNITS)

TABLE 119 AUSTRALIA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (ASP)

TABLE 120 AUSTRALIA KNEE CARTILAGE REPAIR MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 121 AUSTRALIA HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 122 AUSTRALIA HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY SIZE, 2021-2030 (USD MILLION)

TABLE 123 AUSTRALIA KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 124 THAILAND KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 125 THAILAND KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (UNITS)

TABLE 126 THAILAND CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 127 THAILAND CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)

TABLE 128 THAILAND CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)

TABLE 129 THAILAND NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 130 THAILAND NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)

TABLE 131 THAILAND NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)

TABLE 132 THAILAND KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 133 THAILAND KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (UNITS)

TABLE 134 THAILAND KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (ASP)

TABLE 135 THAILAND KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (USD MILLION)

TABLE 136 THAILAND KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (UNITS)

TABLE 137 THAILAND KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030, (ASP)

TABLE 138 THAILAND KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 139 THAILAND KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (UNITS)

TABLE 140 THAILAND KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (ASP)

TABLE 141 THAILAND KNEE CARTILAGE REPAIR MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 142 THAILAND HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 143 THAILAND HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY SIZE, 2021-2030 (USD MILLION)

TABLE 144 THAILAND KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 145 MALAYSIA KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 146 MALAYSIA KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (UNITS)

TABLE 147 MALAYSIA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 148 MALAYSIA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)

TABLE 149 MALAYSIA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)

TABLE 150 MALAYSIA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 151 MALAYSIA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)

TABLE 152 MALAYSIA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)

TABLE 153 MALAYSIA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 154 MALAYSIA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (UNITS)

TABLE 155 MALAYSIA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (ASP)

TABLE 156 MALAYSIA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (USD MILLION)

TABLE 157 MALAYSIA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (UNITS)

TABLE 158 MALAYSIA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030, (ASP)

TABLE 159 MALAYSIA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 160 MALAYSIA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (UNITS)

TABLE 161 MALAYSIA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (ASP)

TABLE 162 MALAYSIA KNEE CARTILAGE REPAIR MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 163 MALAYSIA HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 164 MALAYSIA HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY SIZE, 2021-2030 (USD MILLION)

TABLE 165 MALAYSIA KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 166 SINGAPORE KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 167 SINGAPORE KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (UNITS)

TABLE 168 SINGAPORE CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 169 SINGAPORE CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)

TABLE 170 SINGAPORE CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)

TABLE 171 SINGAPORE NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 172 SINGAPORE NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)

TABLE 173 SINGAPORE NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)

TABLE 174 SINGAPORE KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 175 SINGAPORE KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (UNITS)

TABLE 176 SINGAPORE KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (ASP)

TABLE 177 SINGAPORE KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (USD MILLION)

TABLE 178 SINGAPORE KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (UNITS)

TABLE 179 SINGAPORE KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030, (ASP)

TABLE 180 SINGAPORE KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 181 SINGAPORE KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (UNITS)

TABLE 182 SINGAPORE KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (ASP)

TABLE 183 SINGAPORE KNEE CARTILAGE REPAIR MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 184 SINGAPORE HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 185 SINGAPORE HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY SIZE, 2021-2030 (USD MILLION)

TABLE 186 SINGAPORE KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 187 INDONESIA KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 188 INDONESIA KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (UNITS)

TABLE 189 INDONESIA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 190 INDONESIA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)

TABLE 191 INDONESIA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)

TABLE 192 INDONESIA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 193 INDONESIA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)

TABLE 194 INDONESIA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)

TABLE 195 INDONESIA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 196 INDONESIA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (UNITS)

TABLE 197 INDONESIA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (ASP)

TABLE 198 INDONESIA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (USD MILLION)

TABLE 199 INDONESIA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (UNITS)

TABLE 200 INDONESIA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030, (ASP)

TABLE 201 INDONESIA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 202 INDONESIA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (UNITS)

TABLE 203 INDONESIA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (ASP)

TABLE 204 INDONESIA KNEE CARTILAGE REPAIR MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 205 INDONESIA HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 206 INDONESIA HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY SIZE, 2021-2030 (USD MILLION)

TABLE 207 INDONESIA KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 208 VIETNAM KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 209 VIETNAM KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (UNITS)

TABLE 210 VIETNAM CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 211 VIETNAM CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)

TABLE 212 VIETNAM CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)

TABLE 213 VIETNAM NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 214 VIETNAM NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)

TABLE 215 VIETNAM NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)

TABLE 216 VIETNAM KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 217 VIETNAM KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (UNITS)

TABLE 218 VIETNAM KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (ASP)

TABLE 219 VIETNAM KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (USD MILLION)

TABLE 220 VIETNAM KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (UNITS)

TABLE 221 VIETNAM KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030, (ASP)

TABLE 222 VIETNAM KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 223 VIETNAM KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (UNITS)

TABLE 224 VIETNAM KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (ASP)

TABLE 225 VIETNAM KNEE CARTILAGE REPAIR MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 226 VIETNAM HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 227 VIETNAM HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY SIZE, 2021-2030 (USD MILLION)

TABLE 228 VIETNAM KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 229 PHILIPPINES KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 230 PHILIPPINES KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (UNITS)

TABLE 231 PHILIPPINES CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 232 PHILIPPINES CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)

TABLE 233 PHILIPPINES CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)

TABLE 234 PHILIPPINES NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 235 PHILIPPINES NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)

TABLE 236 PHILIPPINES NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)

TABLE 237 PHILIPPINES KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 238 PHILIPPINES KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (UNITS)

TABLE 239 PHILIPPINES KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (ASP)

TABLE 240 PHILIPPINES KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (USD MILLION)

TABLE 241 PHILIPPINES KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (UNITS)

TABLE 242 PHILIPPINES KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030, (ASP)

TABLE 243 PHILIPPINES KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 244 PHILIPPINES KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (UNITS)

TABLE 245 PHILIPPINES KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (ASP)

TABLE 246 PHILIPPINES KNEE CARTILAGE REPAIR MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 247 PHILIPPINES HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 248 PHILIPPINES HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY SIZE, 2021-2030 (USD MILLION)

TABLE 249 PHILIPPINES KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 250 REST OF ASIA PACIFIC KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 251 REST OF ASIA PACIFIC KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (UNITS)

图片列表

FIGURE 1 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: SEGMENTATION

FIGURE 2 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: DATA TRIANGULATION

FIGURE 3 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: DROC ANALYSIS

FIGURE 4 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS

FIGURE 5 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: DBMR POSITION GRID

FIGURE 8 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: APPLICATION COVERAGE GRID

FIGURE 9 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: SEGMENTATION

FIGURE 10 INCREASE IN THE PREVALENCE OF KNEE DISORDERS AND A RISE IN THE NUMBER OF KNEE SURGERIES ARE EXPECTED TO DRIVE ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET

FIGURE 11 CELL-BASED SEGMENT IS EXPECTED TO HAVE THE LARGEST SHARE OF THE ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET FROM 2023 & 2030

FIGURE 12 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET

FIGURE 13 NUMBER OF TOTAL KNEE ARTHROPLASTIES FROM 2011-2019 IN CHINA

FIGURE 14 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY PRODUCT, 2022

FIGURE 15 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY PRODUCT, 2023-2030 (USD MILLION)

FIGURE 16 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY PRODUCT, CAGR (2023-2030)

FIGURE 17 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY PRODUCT, LIFELINE CURVE

FIGURE 18 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY MODALITY, 2022

FIGURE 19 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY MODALITY, 2023-2030 (USD MILLION)

FIGURE 20 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY MODALITY, CAGR (2023-2030)

FIGURE 21 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY MODALITY, LIFELINE CURVE

FIGURE 22 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY CARTILAGE TYPE, 2022

FIGURE 23 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY CARTILAGE TYPE, 2023-2030 (USD MILLION)

FIGURE 24 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY CARTILAGE TYPE, CAGR (2023-2030)

FIGURE 25 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY CARTILAGE TYPE, LIFELINE CURVE

FIGURE 26 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY APPLICATION, 2022

FIGURE 27 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY APPLICATION, 2023-2030 (USD MILLION)

FIGURE 28 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY APPLICATION, CAGR (2023-2030)

FIGURE 29 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 30 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY END USER, 2022

FIGURE 31 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY END USER, 2023-2030 (USD MILLION)

FIGURE 32 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY END USER, CAGR (2023-2030)

FIGURE 33 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY END USER, LIFELINE CURVE

FIGURE 34 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY DISTRIBUTION CHANNEL, 2022

FIGURE 35 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)

FIGURE 36 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)

FIGURE 37 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 38 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: SNAPSHOT (2022)

FIGURE 39 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY COUNTRY (2022)

FIGURE 40 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY COUNTRY (2023 & 2030)

FIGURE 41 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY COUNTRY (2022 & 2030)

FIGURE 42 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY PRODUCT (2023-2030)

FIGURE 43 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: COMPANY SHARE 2022 (%)

查看详细信息 Right Arrow

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The Asia-Pacific Knee Cartilage Repair Market is projected to grow at a CAGR of 11.1% during the forecast period by 2030.
The Asia-Pacific Knee Cartilage Repair Market is segmented on the basis of product, modality, cartilage type, application, end user, and distribution channel.
The major players in the Asia-Pacific Knee Cartilage Repair Market are Stryker, Zimmer Biomet, B. Braun Melsungen AG, Smith & Nephew, BioTissue, CONMED, DePuy Synthes Companies (A part of Johnson & Johnson Medical Devices Companies), Arthrex, Inc., etc.
The countries covered in the Asia-Pacific Knee Cartilage Repair Market are Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, and Rest of Asia-Pacific.